Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic Cancer

PURPOSE: Impaired glucose metabolism is present in most patients with pancreatic ductal adenocarcinoma (PDAC). Whereas previous studies have focused on pre-treatment glycemic indices and prognosis in those with concomitant diabetes, the effects of glycemic control during chemotherapy treatment on pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alpertunga, Ipek, Sadiq, Rabail, Pandya, Deep, Lo, Tammy, Dulgher, Maxim, Evans, Sarah, Bennett, Bridget, Rennert, Nancy, Frank, Richard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947820/
https://www.ncbi.nlm.nih.gov/pubmed/33718132
http://dx.doi.org/10.3389/fonc.2021.571855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947820/
https://www.ncbi.nlm.nih.gov/pubmed/33718132
http://dx.doi.org/10.3389/fonc.2021.571855

Ejemplares similares